2025-08-09
#reports #VERI
[Veritone](https://eninvs.com/all.php?name=VERI) (Software — Infrastructure) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191327)
(2025-08-07, After Market Close):
- Revenue -22.6% YoY (vs -31.3% in previous quarter and historical rate -10.5%)
- EBITDA margin -50.0% decreased compared to -35.5% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) -$0 bln (negative), 5.5% of market cap
- EV/Sales multiple is 2.6x
At the opening of the session the share price went up +9.5% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #UFPT
[UFP Technologies](https://eninvs.com/all.php?name=UFPT) (Medical Devices) reported for 2025 q2
(2025-08-04, After Market Close):
- Revenue +37.3% YoY (vs +41.0% in previous quarter and historical rate +32.8%)
- EBITDA +30% YoY (vs +36.8% in previous quarter and historical rate +49.4%)
- EBITDA margin 17.2% decreased compared to 18.2% same period last year
- Net Debt decreased by $20 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 9.5% of market cap
- EV/EBITDA multiple is 15.9x compared to historical level (75th percentile) of 26.4x
- EV/Sales multiple is 2.9x
At the opening of the session the share price went up +2.1% vs S&P500 +0.1%
------------------------------------------------
2025-08-09
#reports #TRGP
[Targa Resources](https://eninvs.com/all.php?name=TRGP) (Energy services provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191314)
(2025-08-07, Before Market Open):
- Revenue +19.6% YoY (vs 0.0% in previous quarter and historical rate -6.7%)
- EBITDA +44.6% YoY (vs -6.6% in previous quarter and historical rate +64.8%)
- EBITDA margin 33.1% increased compared to 27.4% same period last year
- Net Debt increased by $874 mln over the past reporting period (2.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 0.1% of market cap
- EV/EBITDA multiple is 12.1x compared to historical level (75th percentile) of 15.5x
- EV/Sales multiple is 3.2x
At the opening of the session the share price went up +2.0% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #SKX
[Skechers U.S.A.](https://eninvs.com/all.php?name=SKX) (Shoe seller) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191305)
(2025-07-28, After Market Close):
- Revenue +13.1% YoY (vs +7.1% in previous quarter and historical rate +11.1%)
- EBITDA +31.7% YoY (vs -10.8% in previous quarter and historical rate +27.1%)
- EBITDA margin 11.2% increased compared to 9.6% same period last year
- Net Debt decreased by $251 mln over the past reporting period (2.7% of market cap)
- FCF (LTM) -$0.9 bln (negative), 9.2% of market cap
- EV/EBITDA multiple is 10x compared to historical level (75th percentile) of 14.3x
- EV/Sales multiple is 1.1x
------------------------------------------------
2025-08-09
#reports #RXST
[RxSight, Inc.](https://eninvs.com/all.php?name=RXST) (Medical Devices) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191372)
(2025-08-07, After Market Close):
- Revenue -2.9% YoY (vs +26.7% in previous quarter and historical rate +67.6%)
- EBITDA margin -38.2% decreased compared to -25.7% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0 bln (negative), 2.5% of market cap
- EV/Sales multiple is -0.1x
At the opening of the session the share price went down -4.4% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #PRCT
[PROCEPT BioRobotics Corporation](https://eninvs.com/all.php?name=PRCT) (Medical Devices) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191397)
(2025-08-06, After Market Close):
- Revenue +49.1% YoY (vs +53.3% in previous quarter and historical rate +75.1%)
- EBITDA margin -26.6% increased compared to -49.1% same period last year
- Net Debt increased by $13 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 6.2% of market cap
- EV/Sales multiple is 5.4x
At the opening of the session the share price went down -8.1% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #PKOH
[Park-Ohio](https://eninvs.com/all.php?name=PKOH) (Specialty Industrial Machinery) reported for 2025 q2
(2025-08-07, After Market Close):
- Revenue -7.6% YoY (vs -3.1% in previous quarter and historical rate +1.1%)
- EBITDA -15.2% YoY (vs -15.6% in previous quarter and historical rate +59.5%)
- EBITDA margin 7.0% decreased compared to 7.6% same period last year
- Net Debt increased by $22 mln over the past reporting period (10.2% of market cap)
- FCF (LTM) +$0 bln (positive), 13.5% of market cap
- EV/EBITDA multiple is 8x compared to historical level (75th percentile) of 12.6x
- EV/Sales multiple is 0.5x
At the opening of the session the share price went down -0.9% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #OGS
[ONE Gas](https://eninvs.com/all.php?name=OGS) (Gas provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191273)
(2025-08-05, After Market Close):
- Revenue +19.8% YoY (vs +23.4% in previous quarter and historical rate +3.9%)
- EBITDA +6.3% YoY (vs +18.0% in previous quarter and historical rate +26.7%)
- EBITDA margin 35.6% decreased compared to 40.1% same period last year
- Net Debt increased by $64 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) -$0.8 bln (negative), 18.3% of market cap
- EV/EBITDA multiple is 20.8x compared to historical level (75th percentile) of 22.7x
- EV/Sales multiple is 6.8x
At the opening of the session the share price went down -0.4% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #OB
[Outbrain Inc.](https://eninvs.com/all.php?name=OB) (Internet Content and Information) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191366)
(2025-05-09, Before Market Open):
- Revenue +60.3% YoY (vs +31.8% in previous quarter and historical rate +2.5%)
- EBITDA margin 0.9% increased compared to -0.9% same period last year
- Net Debt decreased by $17 mln over the past reporting period (8.0% of market cap)
- FCF (LTM) -$0.7 bln (negative), 308.5% of market cap
- EV/Sales multiple is 0.6x
At the opening of the session the share price went down -9.9% vs S&P500 +0.3%
------------------------------------------------
2025-08-09
#reports #NWN
[Northwest Natural Company](https://eninvs.com/all.php?name=NWN) (Utilities — Regulated Gas) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191269)
(2025-08-05, Before Market Open):
- Revenue +11.3% YoY (vs +14.1% in previous quarter and historical rate +10.2%)
- EBITDA +120% YoY (vs +39.9% in previous quarter and historical rate +31.0%)
- EBITDA margin 46.6% increased compared to 23.6% same period last year
- Net Debt increased by $74 mln over the past reporting period (4.8% of market cap)
- FCF (LTM) -$0.6 bln (negative), 37.3% of market cap
- EV/EBITDA multiple is 8.7x compared to historical level (75th percentile) of 10.6x
- EV/Sales multiple is 3.2x
At the opening of the session the share price went up +1.3% vs S&P500 +0.1%
------------------------------------------------
2025-08-09
#reports #DIBS
[1stdibs.Com, Inc.](https://eninvs.com/all.php?name=DIBS) (Internet Retail) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191354)
(2025-08-06, Before Market Open):
- Revenue 0% YoY (vs +4.5% in previous quarter and historical rate -5.0%)
- EBITDA margin -22.7% increased compared to -27.3% same period last year
- Net Debt increased by $6 mln over the past reporting period (6.5% of market cap)
- FCF (LTM) -$0 bln (negative), 7.5% of market cap
- EV/Sales multiple is 0.2x
At the opening of the session the share price went up +3.0% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #BVS
[Bioventus Inc.](https://eninvs.com/all.php?name=BVS) (Medical Devices) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191348)
(2025-08-06, Before Market Open):
- Revenue -2% YoY (vs -3.9% in previous quarter and historical rate +3.1%)
- EBITDA +255.6% YoY (vs 0.0% in previous quarter and historical rate +68.0%)
- EBITDA margin 43.2% increased compared to 11.9% same period last year
- Net Debt decreased by $12 mln over the past reporting period (2.6% of market cap)
- FCF (LTM) +$0 bln (positive), 6.3% of market cap
- EV/EBITDA multiple is 4.4x compared to historical level (75th percentile) of 18.8x
- EV/Sales multiple is 1.4x
At the opening of the session the share price went up +5.7% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #BMBL
[Bumble Inc.](https://eninvs.com/all.php?name=BMBL) (Software — Application) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191344)
(2025-08-06, After Market Close):
- Revenue -7.8% YoY (vs -7.8% in previous quarter and historical rate +7.5%)
- EBITDA -581.2% YoY (vs -18.2% in previous quarter and historical rate +18.3%)
- EBITDA margin -133.9% decreased compared to 25.7% same period last year
- Net Debt decreased by $174 mln over the past reporting period (21.2% of market cap)
- FCF (LTM) +$0.2 bln (positive), 24.0% of market cap
- EV/Sales multiple is 1.6x
At the opening of the session the share price went down -15.0% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #OPEN
[Opendoor Technologies](https://eninvs.com/all.php?name=OPEN) (Real Estate Services) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191086)
(2025-08-05, After Market Close):
- Revenue -70.6% YoY (vs -2.4% in previous quarter and historical rate -9.1%)
- EBITDA margin 0.6% increased compared to -7.2% same period last year
- Net Debt decreased by $565 mln over the past reporting period (40.0% of market cap)
- FCF (LTM) -$0.6 bln (negative), 41.1% of market cap
- EV/EBITDA multiple is 8.4x compared to historical level (75th percentile) of 80.3x
- EV/Sales multiple is 0.3x
At the opening of the session the share price went down -25.0% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #NR
[Newpark Resources](https://eninvs.com/all.php?name=NR) (Oil and Gas Equipment and Services) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191265)
(2024-11-07, After Market Close):
- Revenue -62% YoY (vs -61.5% in previous quarter and historical rate -20.2%)
- EBITDA -14.3% YoY (vs 0.0% in previous quarter and historical rate +32.6%)
- EBITDA margin 26.5% increased compared to 11.7% same period last year
- Net Debt decreased by $5 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0 bln (positive), 6.6% of market cap
- EV/EBITDA multiple is 10x compared to historical level (75th percentile) of 14.6x
- EV/Sales multiple is 2.6x
At the opening of the session the share price went down -6.1% vs S&P500 -0.1%
------------------------------------------------
2025-08-09
#reports #LPX
[Louisiana-Pacific Corporation](https://eninvs.com/all.php?name=LPX) (Building products manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191090)
(2025-08-06, Before Market Open):
- Revenue -7.2% YoY (vs 0.0% in previous quarter and historical rate -10.8%)
- EBITDA -48.4% YoY (vs -11.9% in previous quarter and historical rate +7.5%)
- EBITDA margin 15.4% decreased compared to 27.6% same period last year
- Net Debt decreased by $78 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.3% of market cap
- EV/EBITDA multiple is 14.2x compared to historical level (75th percentile) of 14.1x
- EV/Sales multiple is 2.6x
At the opening of the session the share price went down -5.6% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #INTT
[inTEST Corporation](https://eninvs.com/all.php?name=INTT) (Semiconductor Equipment and Materials) reported for 2025 q2
(2025-08-06, Before Market Open):
- Revenue -17.6% YoY (vs -10.0% in previous quarter and historical rate +10.2%)
- EBITDA -50% YoY (vs -150.0% in previous quarter)
- EBITDA margin 3.6% decreased compared to 5.9% same period last year
- Net Debt increased by $1 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) +$0 bln (positive), 15.1% of market cap
- EV/EBITDA multiple is 17.4x compared to historical level (75th percentile) of 13.1x
- EV/Sales multiple is 0.7x
At the opening of the session the share price went up +4.3% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #GNRC
[Generac](https://eninvs.com/all.php?name=GNRC) (Power generation equipment manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191225)
(2025-07-30, Before Market Open):
- Revenue +6.3% YoY (vs +6.0% in previous quarter and historical rate +0.6%)
- EBITDA +10.7% YoY (vs +23.8% in previous quarter and historical rate +4.3%)
- EBITDA margin 12.6% increased compared to 12.1% same period last year
- Net Debt increased by $77 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0.3 bln (positive), 2.6% of market cap
- EV/EBITDA multiple is 20.1x compared to historical level (75th percentile) of 21.8x
- EV/Sales multiple is 2.9x
At the opening of the session the share price went up +9.0% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #GMED
[Globus Medical](https://eninvs.com/all.php?name=GMED) (Medical equipment developer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191222)
(2025-08-07, After Market Close):
- Revenue +18.3% YoY (vs -1.5% in previous quarter and historical rate +45.7%)
- EBITDA +30.1% YoY (vs +158.7% in previous quarter and historical rate +53.4%)
- EBITDA margin 19.7% increased compared to 17.9% same period last year
- Net Debt increased by $261 mln over the past reporting period (3.3% of market cap)
- FCF (LTM) +$0.6 bln (positive), 7.4% of market cap
- EV/EBITDA multiple is 14.3x compared to historical level (75th percentile) of 30.9x
- EV/Sales multiple is 3x
At the opening of the session the share price went up +3.6% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #EYPT
[EyePoint Pharmaceuticals](https://eninvs.com/all.php?name=EYPT) (Biotechnology) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191204)
(2025-08-06, Before Market Open):
- Revenue -44.4% YoY (vs +100.0% in previous quarter and historical rate +9.0%)
- EBITDA margin -1240.0% decreased compared to -377.8% same period last year
- Net Debt increased by $62 mln over the past reporting period (8.7% of market cap)
- FCF (LTM) +$0.1 bln (positive), 9.0% of market cap
- EV/Sales multiple is 9.2x
At the opening of the session the share price went down -9.8% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #CQP
[Cheniere Energy Partners](https://eninvs.com/all.php?name=CQP) (Oil and Gas Midstream) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191176)
(2025-08-04, Before Market Open):
- Revenue +29.6% YoY (vs +30.2% in previous quarter and historical rate +1.4%)
- EBITDA +104.2% YoY (vs +142.5% in previous quarter and historical rate +53.9%)
- EBITDA margin 77.8% increased compared to 49.4% same period last year
- Net Debt decreased by $140 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.9 bln (positive), 3.4% of market cap
- EV/EBITDA multiple is 6.6x compared to historical level (75th percentile) of 11.6x
- EV/Sales multiple is 4.2x
------------------------------------------------
2025-08-09
#reports #BKD
[Brookdale Senior Living](https://eninvs.com/all.php?name=BKD) (Medical Care Facilities) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191146)
(2025-08-06, After Market Close):
- Revenue +4.5% YoY (vs +4.0% in previous quarter and historical rate +6.5%)
- EBITDA +0.9% YoY (vs +14.8% in previous quarter and historical rate +16.1%)
- EBITDA margin 13.7% decreased compared to 14.1% same period last year
- Net Debt decreased by $57 mln over the past reporting period (4.2% of market cap)
- FCF (LTM) -$1 bln (negative), 73.6% of market cap
- EV/EBITDA multiple is 14.8x compared to historical level (75th percentile) of 15.3x
- EV/Sales multiple is 2.1x
At the opening of the session the share price went down -5.6% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #AMRX
[Amneal Pharmaceuticals](https://eninvs.com/all.php?name=AMRX) (Drug Manufacturers — Specialty and Generic) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191121)
(2025-08-05, Before Market Open):
- Revenue +3.3% YoY (vs +5.5% in previous quarter and historical rate +13.1%)
- EBITDA +33.6% YoY (vs +136.8% in previous quarter and historical rate +56.5%)
- EBITDA margin 23.6% increased compared to 18.2% same period last year
- Net Debt decreased by $17 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 5.3% of market cap
- EV/EBITDA multiple is 8.4x compared to historical level (75th percentile) of 10.3x
- EV/Sales multiple is 1.8x
At the opening of the session the share price went up +4.1% vs S&P500 +0.1%
------------------------------------------------
2025-08-09
#reports #AHT
[Ashford Hospitality Trust](https://eninvs.com/all.php?name=AHT) (REIT — Hotel and Motel) reported for 2025 q2
(2025-02-27, After Market Close):
- Revenue -4.4% YoY (vs -8.9% in previous quarter and historical rate +3.1%)
- EBITDA -50.9% YoY (vs -48.7% in previous quarter and historical rate +18.0%)
- EBITDA margin 28.1% decreased compared to 54.7% same period last year
- Net Debt decreased by $15 mln over the past reporting period (46.7% of market cap)
- FCF (LTM) -$0 bln (negative), 115.2% of market cap
- EV/Sales multiple is -0.1x
At the opening of the session the share price went down -2.4% vs S&P500 -0.3%
------------------------------------------------
2025-08-09
#reports #AEYE
[AudioEye](https://eninvs.com/all.php?name=AEYE) (Software — Application) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191110)
(2025-08-07, After Market Close):
- Revenue +25% YoY (vs +25.0% in previous quarter and historical rate +14.0%)
- Net Debt increased by $2 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) -$0 bln (negative), 1.6% of market cap
- EV/Sales multiple is 3.4x
At the opening of the session the share price went down -5.4% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #CACI
@ cybersecurity
[CACI International](https://eninvs.com/all.php?name=CACI) (Cyber security solutions and IT services provider) reported for [2025 q2](https://eninvs.com/press_release.php?ticker=CACI&q=2025 q2&id=769629)
(2024-08-07, After Market Close):
- Revenue +13.1% YoY (vs +11.9% in previous quarter and historical rate +11.7%)
- EBITDA +12.9% YoY (vs +39.4% in previous quarter and historical rate +16.1%)
- EBITDA margin 11.4% has not changed compared to 11.4% same period last year
- Net Debt decreased by $71 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) -$1.5 bln (negative), 13.8% of market cap
- EV/EBITDA multiple is 14.1x compared to historical level (75th percentile) of 14.4x
- EV/Sales multiple is 1.6x
At the opening of the session the share price went up +1.0% vs S&P500 +1.0%
------------------------------------------------
2025-08-09
#reports #ZVIA
[Zevia PBC](https://eninvs.com/all.php?name=ZVIA) (Beverages — Non-Alcoholic) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190812)
(2025-08-06, After Market Close):
- Revenue +12.5% YoY (vs -2.6% in previous quarter and historical rate -0.4%)
- EBITDA margin -2.2% increased compared to -17.5% same period last year
- Net Debt increased by $2 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) -$0 bln (negative), 4.3% of market cap
- EV/Sales multiple is 1.1x
At the opening of the session the share price went up +4.7% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #ZETA
[Zeta Global Holdings Corp.](https://eninvs.com/all.php?name=ZETA) (Software — Application) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190811)
(2025-08-05, After Market Close):
- Revenue +35.1% YoY (vs +35.4% in previous quarter and historical rate +31.3%)
- EBITDA margin 3.9% increased compared to -6.1% same period last year
- Net Debt decreased by $1 mln over the past reporting period (0.0% of market cap)
- FCF (LTM) +$0.2 bln (positive), 5.0% of market cap
- EV/EBITDA multiple is 146.6x compared to historical level (75th percentile) of 3125x
- EV/Sales multiple is 3.3x
At the opening of the session the share price went up +16.9% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #ZBRA
[Zebra Technologies](https://eninvs.com/all.php?name=ZBRA) (Mobile computer manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191075)
(2025-08-05, Before Market Open):
- Revenue +6.2% YoY (vs +11.3% in previous quarter and historical rate -1.6%)
- EBITDA +7.2% YoY (vs +16.8% in previous quarter and historical rate +21.8%)
- EBITDA margin 17.3% increased compared to 17.2% same period last year
- Net Debt increased by $6 mln over the past reporting period (0.0% of market cap)
- EV/EBITDA multiple is 20x compared to historical level (75th percentile) of 22.9x
- EV/Sales multiple is 3.6x
At the opening of the session the share price went up +2.7% vs S&P500 +0.1%
------------------------------------------------
2025-08-09
#reports #YELP
[Yelp](https://eninvs.com/all.php?name=YELP) (Crowdsourcing platform) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190803)
(2025-08-07, After Market Close):
- Revenue +3.6% YoY (vs +7.8% in previous quarter and historical rate +9.2%)
- EBITDA +34.7% YoY (vs +100.0% in previous quarter and historical rate +51.5%)
- EBITDA margin 17.8% increased compared to 13.7% same period last year
- Net Debt increased by $20 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$0 bln (positive), 1.8% of market cap
- EV/EBITDA multiple is 6.8x compared to historical level (75th percentile) of 21x
- EV/Sales multiple is 1.2x
At the opening of the session the share price went down -6.8% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #XRAY
[DENTSPLY SIRONA](https://eninvs.com/all.php?name=XRAY) (Dental materials and equipment manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191072)
(2025-08-07, Before Market Open):
- Revenue -4.9% YoY (vs -7.8% in previous quarter and historical rate +4.0%)
- EBITDA -214.6% YoY (vs +31.1% in previous quarter and historical rate -49.8%)
- EBITDA margin -10.0% decreased compared to 8.3% same period last year
- Net Debt increased by $68 mln over the past reporting period (2.4% of market cap)
- FCF (LTM) -$0.1 bln (negative), 2.8% of market cap
- EV/Sales multiple is 0.9x
At the opening of the session the share price went up +4.4% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #XPOF
[Xponential Fitness, Inc.](https://eninvs.com/all.php?name=XPOF) (Leisure) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190800)
(2025-08-07, After Market Close):
- Revenue -1.3% YoY (vs -3.7% in previous quarter and historical rate +18.6%)
- EBITDA +800% YoY (vs +8.3% in previous quarter and historical rate +12.4%)
- EBITDA margin 23.7% increased compared to 2.6% same period last year
- Net Debt decreased by $1.5 bln since the start of the year (635.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 35.8% of market cap
- EV/Sales multiple is 3.2x
At the opening of the session the share price went down -10.6% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #XPER
[Xperi](https://eninvs.com/all.php?name=XPER) (Semiconductor Equipment and Materials) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190797)
(2025-07-28, After Market Close):
- Revenue -11.7% YoY (vs -4.2% in previous quarter and historical rate -17.5%)
- EBITDA margin -7.5% increased compared to -15.8% same period last year
- Net Debt decreased by $7 mln over the past reporting period (2.7% of market cap)
- FCF (LTM) -$0 bln (negative), 5.1% of market cap
- EV/Sales multiple is 0.5x
At the opening of the session the share price went down -8.6% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #XPEL
[XPEL](https://eninvs.com/all.php?name=XPEL) (Automotive surface protection products manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190794)
(2025-08-06, Before Market Open):
- Revenue +13.6% YoY (vs +15.6% in previous quarter and historical rate +15.5%)
- EBITDA 0% YoY (vs +18.2% in previous quarter and historical rate +12.6%)
- EBITDA margin 16.8% decreased compared to 19.1% same period last year
- Net Debt decreased by $25 mln over the past reporting period (2.7% of market cap)
- FCF (LTM) +$0 bln (positive), 2.5% of market cap
- EV/EBITDA multiple is 13.2x compared to historical level (75th percentile) of 31.7x
- EV/Sales multiple is 2x
At the opening of the session the share price went up +12.9% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #XMTR
[Xometry, Inc.](https://eninvs.com/all.php?name=XMTR) (Specialty Industrial Machinery) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190791)
(2025-08-05, Before Market Open):
- Revenue +22.6% YoY (vs +22.8% in previous quarter and historical rate +27.7%)
- EBITDA margin -3.7% increased compared to -9.0% same period last year
- Net Debt increased by $46 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) -$0 bln (negative), 0.3% of market cap
- EV/Sales multiple is 3.6x
At the opening of the session the share price went up +24.9% vs S&P500 +0.1%
------------------------------------------------
2025-08-09
#reports #WWW
[Wolverine World Wide](https://eninvs.com/all.php?name=WWW) (Clothing/shoes/accessories manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190789)
(2025-08-06, Before Market Open):
- Revenue +11.5% YoY (vs +4.3% in previous quarter and historical rate -10.0%)
- EBITDA +26.2% YoY (vs +550.0% in previous quarter and historical rate +23.6%)
- EBITDA margin 11.2% increased compared to 9.9% same period last year
- Net Debt decreased by $31 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 3.9% of market cap
- EV/EBITDA multiple is 16.6x compared to historical level (75th percentile) of 13x
- EV/Sales multiple is 1.6x
At the opening of the session the share price went up +4.3% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #WTTR
[Select Energy Services](https://eninvs.com/all.php?name=WTTR) (Complete water supply solution provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190785)
(2025-08-05, After Market Close):
- Revenue -0.3% YoY (vs +1.9% in previous quarter and historical rate +24.6%)
- EBITDA -1.7% YoY (vs +22.2% in previous quarter and historical rate +49.3%)
- EBITDA margin 15.9% decreased compared to 16.2% same period last year
- Net Debt decreased by $1 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) -$0.1 bln (negative), 17.8% of market cap
- EV/EBITDA multiple is 5.1x compared to historical level (75th percentile) of 5.3x
- EV/Sales multiple is 0.8x
At the opening of the session the share price went down -6.8% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #WRBY
[Warby Parker Inc.](https://eninvs.com/all.php?name=WRBY) (Medical Instruments and Supplies) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190782)
(2025-08-07, Before Market Open):
- Revenue +13.8% YoY (vs +12.0% in previous quarter and historical rate +13.1%)
- EBITDA margin -2.3% increased compared to -4.8% same period last year
- Net Debt decreased by $17 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0 bln (positive), 0.4% of market cap
- EV/EBITDA multiple is 139.4x compared to historical level (75th percentile) of 355.2x
- EV/Sales multiple is 3.4x
At the opening of the session the share price went up +11.1% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #WLKP
[Westlake Chemical Partners LP](https://eninvs.com/all.php?name=WLKP) (Chemicals) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190781)
(2025-08-05, Before Market Open):
- Revenue +4.6% YoY (vs -16.5% in previous quarter and historical rate -6.1%)
- EBITDA -7.4% YoY (vs -39.8% in previous quarter and historical rate +15.0%)
- EBITDA margin 8.4% decreased compared to 9.5% same period last year
- Net Debt increased by $43 mln over the past reporting period (5.6% of market cap)
- FCF (LTM) +$0 bln (positive), 0.4% of market cap
- EV/EBITDA multiple is 4.5x compared to historical level (75th percentile) of 4.4x
- EV/Sales multiple is 1.5x
------------------------------------------------
2025-08-09
#reports #WEYS
[Weyco Group](https://eninvs.com/all.php?name=WEYS) (Footwear and Accessories) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190776)
(2025-03-11, After Market Close):
- Revenue -9.4% YoY (vs -5.6% in previous quarter and historical rate -2.4%)
- EBITDA -42.9% YoY (vs -11.1% in previous quarter and historical rate +3.7%)
- EBITDA margin 6.9% decreased compared to 10.9% same period last year
- Net Debt decreased by $5 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) -$0 bln (negative), 2.1% of market cap
- EV/EBITDA multiple is 6.4x compared to historical level (75th percentile) of 6.5x
- EV/Sales multiple is 0.8x
At the opening of the session the share price went neutrally vs S&P500 +0.9%
------------------------------------------------
2025-08-09
#reports #WEN
[Wendys](https://eninvs.com/all.php?name=WEN) (Restaurants) reported for 2025 q2
(2025-08-08, Before Market Open):
- Revenue -1.8% YoY (vs -2.2% in previous quarter and historical rate +21.9%)
- EBITDA +8.7% YoY (vs +2.4% in previous quarter and historical rate -6.5%)
- EBITDA margin 20.0% increased compared to 18.0% same period last year
- Net Debt increased by $54 mln over the past reporting period (2.4% of market cap)
- FCF (LTM) +$0 bln (positive), 0.3% of market cap
- EV/EBITDA multiple is 14.9x compared to historical level (75th percentile) of 18.1x
- EV/Sales multiple is 2.7x
At the opening of the session the share price went up +0.5% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #VTRS
[Viatris](https://eninvs.com/all.php?name=VTRS) (Medicines manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190772)
(2025-08-07, Before Market Open):
- Revenue -5.7% YoY (vs -11.2% in previous quarter and historical rate -6.3%)
- EBITDA +73.4% YoY (vs -818.6% in previous quarter and historical rate -19.0%)
- EBITDA margin 31.2% increased compared to 17.0% same period last year
- Net Debt increased by $475 mln over the past reporting period (4.0% of market cap)
- FCF (LTM) +$2.3 bln (positive), 19.6% of market cap
- EV/EBITDA multiple is 88.2x compared to historical level (75th percentile) of 8.7x
- EV/Sales multiple is 1.8x
At the opening of the session the share price went up +2.9% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #VRRM
[Verra Mobility](https://eninvs.com/all.php?name=VRRM) (Security and Protection Services) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190770)
(2025-08-06, After Market Close):
- Revenue +6.3% YoY (vs +6.2% in previous quarter and historical rate +9.7%)
- EBITDA +3.4% YoY (vs +4.9% in previous quarter and historical rate -7.9%)
- EBITDA margin 39.0% decreased compared to 40.1% same period last year
- Net Debt decreased by $52 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) -$0 bln (negative), 0.2% of market cap
- EV/EBITDA multiple is 18.4x compared to historical level (75th percentile) of 17.9x
- EV/Sales multiple is 5.1x
At the opening of the session the share price went down -0.1% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #VREX
[Varex Imaging](https://eninvs.com/all.php?name=VREX) (Components for X-ray detectors manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190769)
(2025-08-07, After Market Close):
- Revenue -2.9% YoY (vs +3.4% in previous quarter and historical rate -1.0%)
- EBITDA -473.7% YoY (vs +116.7% in previous quarter and historical rate -20.2%)
- EBITDA margin -35.0% decreased compared to 9.1% same period last year
- Net Debt decreased by $130 mln over the past reporting period (34.2% of market cap)
- FCF (LTM) -$0.1 bln (negative), 23.1% of market cap
- EV/Sales multiple is 0.8x
At the opening of the session the share price went up +10.0% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #VHI
[Valhi](https://eninvs.com/all.php?name=VHI) (Chemicals) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190767)
(2025-08-07, After Market Close):
- Revenue -1.4% YoY (vs -9.8% in previous quarter and historical rate -4.4%)
- EBITDA -55% YoY (vs +35.7% in previous quarter and historical rate +37.2%)
- EBITDA margin 5.5% decreased compared to 12.0% same period last year
- Net Debt increased by $39 mln over the past reporting period (8.8% of market cap)
- FCF (LTM) -$0.3 bln (negative), 73.8% of market cap
- EV/EBITDA multiple is 3.7x compared to historical level (75th percentile) of 12.3x
- EV/Sales multiple is 0.6x
At the opening of the session the share price went up +2.0% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #VECO
[Veeco Instruments](https://eninvs.com/all.php?name=VECO) (Semiconductor Equipment and Materials) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190765)
(2025-08-06, After Market Close):
- Revenue -5.7% YoY (vs -4.0% in previous quarter and historical rate +4.1%)
- EBITDA -26.1% YoY (vs -32.1% in previous quarter and historical rate -3.1%)
- EBITDA margin 10.2% decreased compared to 13.1% same period last year
- Net Debt decreased by $26 mln over the past reporting period (1.9% of market cap)
- FCF (LTM) +$0.1 bln (positive), 5.7% of market cap
- EV/EBITDA multiple is 16.1x compared to historical level (75th percentile) of 18.4x
- EV/Sales multiple is 1.8x
At the opening of the session the share price went up +14.0% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #VCYT
[Veracyte](https://eninvs.com/all.php?name=VCYT) (Medical services provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190762)
(2025-08-06, After Market Close):
- Revenue +14% YoY (vs +17.5% in previous quarter and historical rate +21.5%)
- EBITDA -100% YoY (vs +700.0% in previous quarter)
- Net Debt decreased by $33 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) +$0 bln (positive), 1.0% of market cap
- EV/EBITDA multiple is 60.2x compared to historical level (75th percentile) of 66.8x
- EV/Sales multiple is 3.9x
At the opening of the session the share price went up +8.5% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #UTI
[Universal Technical Institute](https://eninvs.com/all.php?name=UTI) (Education and Training Services) reported for 2025 q2
(2025-08-06, After Market Close):
- Revenue +15.3% YoY (vs +12.5% in previous quarter and historical rate +35.7%)
- EBITDA +22.2% YoY (vs +72.2% in previous quarter and historical rate +56.7%)
- EBITDA margin 10.8% increased compared to 10.2% same period last year
- Net Debt increased by $29 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) -$0 bln (negative), 3.2% of market cap
- EV/EBITDA multiple is 12.1x compared to historical level (75th percentile) of 14.4x
- EV/Sales multiple is 1.7x
At the opening of the session the share price went down -5.6% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #UEIC
[Universal Electronics](https://eninvs.com/all.php?name=UEIC) ( Innovative products manufacturer) reported for 2025 q2
(2025-08-07, After Market Close):
- Revenue +8.9% YoY (vs 0.0% in previous quarter and historical rate -10.3%)
- EBITDA margin 1.0% increased compared to -4.4% same period last year
- Net Debt decreased by $8 mln over the past reporting period (12.2% of market cap)
- FCF (LTM) +$0 bln (positive), 24.5% of market cap
- EV/EBITDA multiple is 34.7x compared to historical level (75th percentile) of 76.5x
- EV/Sales multiple is 0.2x
At the opening of the session the share price went down -3.5% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #UBER
[Uber Technologies](https://eninvs.com/all.php?name=UBER) (Ride hailing services provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190751)
(2025-08-06, Before Market Open):
- Revenue +18.2% YoY (vs +13.8% in previous quarter and historical rate +24.6%)
- EBITDA +66.9% YoY (vs +284.2% in previous quarter and historical rate +79.4%)
- EBITDA margin 12.9% increased compared to 9.1% same period last year
- Net Debt decreased by $24 mln over the past reporting period (0.0% of market cap)
- FCF (LTM) +$5.5 bln (positive), 3.1% of market cap
- EV/EBITDA multiple is 34.8x compared to historical level (75th percentile) of 76.2x
- EV/Sales multiple is 3.8x
At the opening of the session the share price went up +1.7% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #TXG
[10X Genomics](https://eninvs.com/all.php?name=TXG) (Medical services provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190746)
(2025-08-07, After Market Close):
- Revenue +13.1% YoY (vs +9.9% in previous quarter and historical rate +9.6%)
- EBITDA margin 22.0% increased compared to -22.2% same period last year
- Net Debt decreased by $14 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 4.0% of market cap
- EV/Sales multiple is 1.6x
At the opening of the session the share price went up +13.2% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #TWLO
[Twilio](https://eninvs.com/all.php?name=TWLO) (Communication services provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190745)
(2025-08-07, After Market Close):
- Revenue +13.4% YoY (vs +11.9% in previous quarter and historical rate +12.0%)
- EBITDA +219.2% YoY (vs +1600.0% in previous quarter and historical rate +100.0%)
- EBITDA margin 6.8% increased compared to 2.4% same period last year
- Net Debt decreased by $93 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) -$0.5 bln (negative), 3.3% of market cap
- EV/EBITDA multiple is 54.8x compared to historical level (75th percentile) of 129.4x
- EV/Sales multiple is 2.9x
At the opening of the session the share price went down -15.5% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #TVTX
[Travere Therapeutics](https://eninvs.com/all.php?name=TVTX) (Biotechnology) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190744)
(2025-08-06, After Market Close):
- Revenue +111.1% YoY (vs +100.0% in previous quarter and historical rate +22.2%)
- EBITDA margin 0.9% increased compared to -107.4% same period last year
- Net Debt decreased by $15 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) -$0 bln (negative), 2.3% of market cap
- EV/Sales multiple is 4.5x
At the opening of the session the share price went up +1.0% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #TTEC
[TTEC](https://eninvs.com/all.php?name=TTEC) (IT services provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190743)
(2025-08-07, After Market Close):
- Revenue -3.7% YoY (vs -7.5% in previous quarter and historical rate -3.1%)
- EBITDA margin 8.2% increased compared to -37.1% same period last year
- Net Debt decreased by $65 mln over the past reporting period (39.8% of market cap)
- FCF (LTM) -$0 bln (negative), 4.3% of market cap
- EV/EBITDA multiple is 6.5x compared to historical level (75th percentile) of 10.8x
- EV/Sales multiple is 0.5x
At the opening of the session the share price went up +12.5% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #TSQ
[Townsquare Media](https://eninvs.com/all.php?name=TSQ) (Advertising Agencies) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190740)
(2025-08-06, Before Market Open):
- Revenue -2.5% YoY (vs -1.0% in previous quarter and historical rate +0.3%)
- EBITDA margin 22.6% increased compared to -13.6% same period last year
- Net Debt decreased by $8 mln over the past reporting period (7.4% of market cap)
- FCF (LTM) +$0 bln (positive), 23.1% of market cap
- EV/EBITDA multiple is 6.8x compared to historical level (75th percentile) of 17.7x
- EV/Sales multiple is 1.3x
At the opening of the session the share price went up +1.0% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #TRUE
[TrueCar](https://eninvs.com/all.php?name=TRUE) (Internet Content and Information) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190736)
(2025-08-06, After Market Close):
- Revenue +11.9% YoY (vs +9.8% in previous quarter and historical rate +0.9%)
- EBITDA margin -10.6% increased compared to -26.2% same period last year
- Net Debt increased by $5 mln over the past reporting period (2.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 55.3% of market cap
- EV/Sales multiple is 0.5x
At the opening of the session the share price went up +1.5% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #TRIP
[TripAdvisor](https://eninvs.com/all.php?name=TRIP) (Travel services provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190734)
(2025-08-07, After Market Close):
- Revenue +6.4% YoY (vs +0.8% in previous quarter and historical rate +17.0%)
- EBITDA +46.4% YoY (vs -14.3% in previous quarter and historical rate +19.0%)
- EBITDA margin 15.5% increased compared to 11.3% same period last year
- Net Debt decreased by $57 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) -$0.4 bln (negative), 16.3% of market cap
- EV/EBITDA multiple is 12.7x compared to historical level (75th percentile) of 14.6x
- EV/Sales multiple is 1.4x
At the opening of the session the share price went up +6.3% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #TOST
[Toast, Inc.](https://eninvs.com/all.php?name=TOST) (Software — Infrastructure) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190727)
(2025-08-05, After Market Close):
- Revenue +24.8% YoY (vs +24.4% in previous quarter and historical rate +36.5%)
- EBITDA +236.1% YoY (vs +8400.0% in previous quarter and historical rate +66.7%)
- EBITDA margin 7.8% increased compared to 2.9% same period last year
- Net Debt decreased by $216 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0.5 bln (positive), 2.4% of market cap
- EV/EBITDA multiple is 63.1x compared to historical level (75th percentile) of 385.2x
- EV/Sales multiple is 3.9x
At the opening of the session the share price went down -7.6% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #TNDM
[Tandem Diabetes Care](https://eninvs.com/all.php?name=TNDM) (Medical equipment manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190725)
(2025-08-06, After Market Close):
- Revenue +8.6% YoY (vs +21.9% in previous quarter and historical rate +10.4%)
- EBITDA margin -19.5% decreased compared to -11.7% same period last year
- Net Debt increased by $9 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) -$0.1 bln (negative), 13.9% of market cap
- EV/Sales multiple is 0.9x
At the opening of the session the share price went down -27.0% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #TNC
[Tennant Company](https://eninvs.com/all.php?name=TNC) (Cleaning equipment manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190724)
(2025-08-06, After Market Close):
- Revenue -3.6% YoY (vs -6.8% in previous quarter and historical rate +5.2%)
- EBITDA -13.5% YoY (vs -33.3% in previous quarter and historical rate +26.4%)
- EBITDA margin 14.1% decreased compared to 15.7% same period last year
- Net Debt decreased by $1 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0 bln (positive), 0.7% of market cap
- EV/EBITDA multiple is 11.5x compared to historical level (75th percentile) of 12x
- EV/Sales multiple is 1.3x
At the opening of the session the share price went up +0.8% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #TMCI
[Treace Medical Concepts, Inc.](https://eninvs.com/all.php?name=TMCI) (Medical Devices) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190722)
(2025-08-07, After Market Close):
- Revenue +6.8% YoY (vs +3.9% in previous quarter and historical rate +24.4%)
- EBITDA margin -29.8% increased compared to -43.2% same period last year
- Net Debt increased by $7 mln over the past reporting period (2.1% of market cap)
- FCF (LTM) -$0 bln (negative), 5.0% of market cap
- EV/Sales multiple is 1.6x
At the opening of the session the share price went down -3.9% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #TKNO
[Alpha Teknova, Inc.](https://eninvs.com/all.php?name=TKNO) (Drug Manufacturers — Specialty and Generic) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190720)
(2025-08-07, After Market Close):
- Revenue 0% YoY (vs +11.1% in previous quarter and historical rate -0.9%)
- EBITDA margin -20.0% increased compared to -40.0% same period last year
- Net Debt increased by $2 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) +$0 bln (positive), 10.1% of market cap
- EV/Sales multiple is 3.2x
At the opening of the session the share price went up +26.3% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #TGLS
[Tecnoglass](https://eninvs.com/all.php?name=TGLS) (Building Materials) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190717)
(2025-08-07, Before Market Open):
- Revenue +16.4% YoY (vs +15.0% in previous quarter and historical rate +21.3%)
- EBITDA +20.7% YoY (vs +42.6% in previous quarter and historical rate +50.4%)
- EBITDA margin 27.3% increased compared to 26.4% same period last year
- Net Debt increased by $19 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0 bln (positive), 1.0% of market cap
- EV/EBITDA multiple is 12.1x compared to historical level (75th percentile) of 13.1x
- EV/Sales multiple is 3.6x
At the opening of the session the share price went up +2.4% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #TCX
[Tucows](https://eninvs.com/all.php?name=TCX) (Domain name registrar) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190713)
(2025-08-07, After Market Close):
- Revenue +10.1% YoY (vs +9.2% in previous quarter and historical rate +5.6%)
- EBITDA +350% YoY (vs +900.0% in previous quarter)
- EBITDA margin 9.2% increased compared to 2.2% same period last year
- Net Debt decreased by $8 mln over the past reporting period (3.7% of market cap)
- FCF (LTM) -$0.3 bln (negative), 136.3% of market cap
- EV/Sales multiple is 1.3x
At the opening of the session the share price went up +2.4% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #TAP
[Molson Coors Beverage](https://eninvs.com/all.php?name=TAP) (Beer maker) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190710)
(2025-08-05, Before Market Open):
- Revenue -2.6% YoY (vs -11.8% in previous quarter and historical rate +6.8%)
- EBITDA -1.7% YoY (vs -24.0% in previous quarter and historical rate +27.6%)
- EBITDA margin 20.2% increased compared to 20.0% same period last year
- Net Debt decreased by $125 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) -$0.5 bln (negative), 4.9% of market cap
- EV/EBITDA multiple is 7.2x compared to historical level (75th percentile) of 16.7x
- EV/Sales multiple is 1.3x
At the opening of the session the share price went up +0.9% vs S&P500 +0.1%
------------------------------------------------
2025-08-09
#reports #SUPN
[Supernus Pharmaceuticals](https://eninvs.com/all.php?name=SUPN) (Pharmaceutical manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191027)
(2025-08-05, After Market Close):
- Revenue -1.8% YoY (vs +4.2% in previous quarter and historical rate +9.8%)
- EBITDA -40% YoY (vs -21.2% in previous quarter and historical rate +30.7%)
- EBITDA margin 9.1% decreased compared to 14.9% same period last year
- Net Debt decreased by $61 mln over the past reporting period (2.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 5.2% of market cap
- EV/EBITDA multiple is 11.3x compared to historical level (75th percentile) of 19x
- EV/Sales multiple is 2.2x
At the opening of the session the share price went up +4.3% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #STIM
[Neuronetics](https://eninvs.com/all.php?name=STIM) (Diagnostics and Research) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190698)
(2025-08-05, Before Market Open):
- Revenue +137.5% YoY (vs +88.2% in previous quarter and historical rate +26.8%)
- EBITDA margin -18.4% increased compared to -50.0% same period last year
- Net Debt increased by $8 mln over the past reporting period (5.3% of market cap)
- FCF (LTM) -$0 bln (negative), 31.7% of market cap
- EV/Sales multiple is 2x
At the opening of the session the share price went down -11.8% vs S&P500 +0.1%
------------------------------------------------
2025-08-09
#reports #SRDX
[Surmodics](https://eninvs.com/all.php?name=SRDX) (Medical device manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191021)
(2025-08-04, Before Market Open):
- Revenue 0% YoY (vs -12.5% in previous quarter and historical rate +11.6%)
- EBITDA margin -10.0% has not changed compared to -10.0% same period last year
- Net Debt increased by $3 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0 bln (positive), 1.0% of market cap
- EV/Sales multiple is 4.2x
At the opening of the session the share price went up +0.1% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #SMCI
[Super Micro Computer](https://eninvs.com/all.php?name=SMCI) (Computer Hardware) reported for 2025 q2
(2025-08-05, After Market Close):
- Revenue +8.5% YoY (vs +19.5% in previous quarter and historical rate +73.8%)
- EBITDA -28% YoY (vs -54.0% in previous quarter and historical rate +69.9%)
- EBITDA margin 4.4% decreased compared to 6.7% same period last year
- Net Debt decreased by $368 mln over the past reporting period (14.1% of market cap)
- EV/EBITDA multiple is 1.7x compared to historical level (75th percentile) of 21.3x
- EV/Sales multiple is 0.1x
At the opening of the session the share price went down -17.3% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #ROCK
[Gibraltar Industries](https://eninvs.com/all.php?name=ROCK) (Engineering materials and metals supplier) reported for 2025 q2
(2025-08-06, Before Market Open):
- Revenue -12.2% YoY (vs -1.0% in previous quarter and historical rate +14.3%)
- EBITDA -1.9% YoY (vs -7.9% in previous quarter and historical rate +24.2%)
- EBITDA margin 17.1% increased compared to 15.3% same period last year
- Net Debt decreased by $14 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 2.9% of market cap
- EV/EBITDA multiple is 6x compared to historical level (75th percentile) of 12x
- EV/Sales multiple is 0.8x
At the opening of the session the share price went down -6.9% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #RGEN
[Repligen](https://eninvs.com/all.php?name=RGEN) (Highly innovative biotechnological technologies developer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190994)
(2025-07-29, Before Market Open):
- Revenue +18.2% YoY (vs +11.9% in previous quarter and historical rate -3.4%)
- EBITDA +240% YoY (vs +92.3% in previous quarter and historical rate -30.2%)
- EBITDA margin 18.7% increased compared to 6.5% same period last year
- Net Debt decreased by $9 mln over the past reporting period (0.1% of market cap)
- EV/EBITDA multiple is 445.1x compared to historical level (75th percentile) of 125x
- EV/Sales multiple is 9.2x
At the opening of the session the share price went up +5.3% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #NTCT
[NetScout Systems](https://eninvs.com/all.php?name=NTCT) (Software provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190963)
(2025-08-07, Before Market Open):
- Revenue +6.9% YoY (vs +1.0% in previous quarter and historical rate -1.0%)
- EBITDA margin 7.5% increased compared to -253.1% same period last year
- Net Debt decreased by $43 mln over the past reporting period (2.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 9.0% of market cap
- EV/EBITDA multiple is 6.3x compared to historical level (75th percentile) of 12.9x
- EV/Sales multiple is 1.3x
At the opening of the session the share price went down -1.5% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #NKTR
[Nektar Therapeutics](https://eninvs.com/all.php?name=NKTR) (Medicines developer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190960)
(2025-08-07, After Market Close):
- Revenue -52.2% YoY (vs -54.5% in previous quarter and historical rate -8.2%)
- EBITDA margin -327.3% decreased compared to -208.7% same period last year
- Net Debt increased by $38 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) -$0 bln (negative), 0.8% of market cap
- EV/Sales multiple is 64.6x
At the opening of the session the share price went up +3.9% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #MSI
[Motorola Solutions](https://eninvs.com/all.php?name=MSI) (Telecom equipment supplier) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190955)
(2025-08-07, After Market Close):
- Revenue 0% YoY (vs +5.8% in previous quarter and historical rate +9.1%)
- EBITDA +0.4% YoY (vs +10.1% in previous quarter and historical rate +15.0%)
- EBITDA margin 27.8% increased compared to 27.7% same period last year
- Net Debt increased by $148 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$0.7 bln (positive), 0.9% of market cap
- EV/EBITDA multiple is 26.2x compared to historical level (75th percentile) of 25.4x
- EV/Sales multiple is 7.4x
At the opening of the session the share price went up +1.5% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #MATW
[Matthews International](https://eninvs.com/all.php?name=MATW) (Memorialization products manufacturer) reported for 2025 q2
(2025-08-05, After Market Close):
- Revenue -18.5% YoY (vs -9.1% in previous quarter and historical rate -2.1%)
- EBITDA +203.3% YoY (vs -8.9% in previous quarter and historical rate +1.8%)
- EBITDA margin 26.1% increased compared to 7.0% same period last year
- Net Debt decreased by $100 mln over the past reporting period (13.5% of market cap)
- FCF (LTM) +$0 bln (positive), 0.7% of market cap
- EV/EBITDA multiple is 10.5x compared to historical level (75th percentile) of 20.7x
- EV/Sales multiple is 0.9x
At the opening of the session the share price went up +1.8% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #IRWD
[Ironwood Pharmaceuticals](https://eninvs.com/all.php?name=IRWD) (Drug Manufacturers — Specialty and Generic) reported for 2025 q2
(2025-08-07, Before Market Open):
- Revenue -9.6% YoY (vs -45.3% in previous quarter and historical rate -9.1%)
- EBITDA +80% YoY (vs -333.3% in previous quarter and historical rate -16.0%)
- EBITDA margin 52.9% increased compared to 26.6% same period last year
- Net Debt increased by $214 mln over the past reporting period (155.1% of market cap)
- FCF (LTM) +$0.2 bln (positive), 176.1% of market cap
- EV/EBITDA multiple is 6.1x compared to historical level (75th percentile) of 7.4x
- EV/Sales multiple is 2.7x
At the opening of the session the share price went up +14.3% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #HSON
[Hudson Global](https://eninvs.com/all.php?name=HSON) (Staffing and Employment Services) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191058)
(2025-08-08, Before Market Open):
- Revenue 0% YoY (vs -5.9% in previous quarter and historical rate +6.1%)
- EV/Sales multiple is 0x
At the opening of the session the share price went up +3.1% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #EEFT
[Euronet Worldwide](https://eninvs.com/all.php?name=EEFT) (Financial services provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190892)
(2025-07-31, After Market Close):
- Revenue +8.9% YoY (vs +6.9% in previous quarter and historical rate +9.0%)
- EBITDA +14.3% YoY (vs +10.3% in previous quarter and historical rate +18.5%)
- EBITDA margin 17.9% increased compared to 17.0% same period last year
- Net Debt increased by $319 mln over the past reporting period (8.0% of market cap)
- EV/EBITDA multiple is 7.9x compared to historical level (75th percentile) of 10.3x
- EV/Sales multiple is 1.3x
At the opening of the session the share price went down -1.2% vs S&P500 -0.8%
------------------------------------------------
2025-08-09
#reports #DIOD
[Diodes](https://eninvs.com/all.php?name=DIOD) ( Semiconductor manufacturer ) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190885)
(2025-08-07, After Market Close):
- Revenue +14.4% YoY (vs +9.9% in previous quarter and historical rate -8.7%)
- EBITDA +15% YoY (vs -31.6% in previous quarter and historical rate -25.9%)
- EBITDA margin 12.6% has not changed compared to 12.5% same period last year
- Net Debt increased by $6 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$0.1 bln (positive), 3.0% of market cap
- EV/EBITDA multiple is 13.8x compared to historical level (75th percentile) of 12.5x
- EV/Sales multiple is 1.5x
At the opening of the session the share price went up +4.5% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #CDNA
[CareDx](https://eninvs.com/all.php?name=CDNA) (Medicine technologies developer ) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190863)
(2025-08-06, After Market Close):
- Revenue +335% YoY (vs +18.1% in previous quarter and historical rate +12.7%)
- EBITDA margin -14.9% increased compared to -45.0% same period last year
- Net Debt increased by $44 mln over the past reporting period (6.7% of market cap)
- FCF (LTM) -$0 bln (negative), 1.5% of market cap
- EV/EBITDA multiple is 9.2x compared to historical level (75th percentile) of 15.6x
- EV/Sales multiple is 1.5x
At the opening of the session the share price went down -7.5% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #BR
[Broadridge Financial Solutions](https://eninvs.com/all.php?name=BR) ( Outsourcing solutions provider ) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190848)
(2025-08-05, Before Market Open):
- Revenue +6.2% YoY (vs +5.0% in previous quarter and historical rate +13.9%)
- EBITDA +6.7% YoY (vs +11.1% in previous quarter and historical rate +7.1%)
- EBITDA margin 43.8% increased compared to 43.6% same period last year
- Net Debt decreased by $425 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) -$0.1 bln (negative), 0.2% of market cap
- EV/EBITDA multiple is 18.5x compared to historical level (75th percentile) of 17.5x
- EV/Sales multiple is 4.9x
At the opening of the session the share price went up +1.0% vs S&P500 +0.1%
------------------------------------------------
2025-08-09
#reports #BDX
[Becton Dickinson](https://eninvs.com/all.php?name=BDX) (Medical devices developer ) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190847)
(2025-08-07, Before Market Open):
- Revenue +10.4% YoY (vs +4.5% in previous quarter and historical rate +3.8%)
- EBITDA +28.2% YoY (vs -11.6% in previous quarter and historical rate +1.6%)
- EBITDA margin 27.2% increased compared to 23.4% same period last year
- Net Debt decreased by $3 mln over the past reporting period (0.0% of market cap)
- FCF (LTM) -$3.8 bln (negative), 6.9% of market cap
- EV/EBITDA multiple is 15x compared to historical level (75th percentile) of 19x
- EV/Sales multiple is 3.5x
At the opening of the session the share price went up +8.7% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #AXL
[American Axle & Manufacturing](https://eninvs.com/all.php?name=AXL) (Auto Parts) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191053)
(2025-08-08, Before Market Open):
- Revenue -5.9% YoY (vs -12.2% in previous quarter and historical rate +3.6%)
- EBITDA -18% YoY (vs -20.5% in previous quarter and historical rate +27.4%)
- EBITDA margin 11.0% decreased compared to 12.6% same period last year
- Net Debt decreased by $38 mln over the past reporting period (6.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 22.4% of market cap
- EV/EBITDA multiple is 4.3x compared to historical level (75th percentile) of 5x
- EV/Sales multiple is 0.5x
At the opening of the session the share price went down -2.4% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #ANIP
[ANI Pharmaceuticals](https://eninvs.com/all.php?name=ANIP) ( Specialty pharmaceutical company) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191051)
(2025-08-08, Before Market Open):
- Revenue +52.9% YoY (vs +43.8% in previous quarter and historical rate +47.9%)
- EBITDA +85% YoY (vs +40.0% in previous quarter and historical rate +63.1%)
- EBITDA margin 17.5% increased compared to 14.5% same period last year
- Net Debt decreased by $69 mln over the past reporting period (4.3% of market cap)
- FCF (LTM) -$0.4 bln (negative), 26.8% of market cap
- EV/EBITDA multiple is 20.5x compared to historical level (75th percentile) of 25.1x
- EV/Sales multiple is 2.7x
At the opening of the session the share price went up +12.8% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #ACMR
[ACM Research](https://eninvs.com/all.php?name=ACMR) (Wet processing technology provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190821)
(2025-08-06, Before Market Open):
- Revenue +6.4% YoY (vs +13.2% in previous quarter and historical rate +46.1%)
- EBITDA -15.5% YoY (vs +2.6% in previous quarter and historical rate +64.2%)
- EBITDA margin 27.9% decreased compared to 35.1% same period last year
- Net Debt increased by $47 mln over the past reporting period (3.1% of market cap)
- FCF (LTM) -$0 bln (negative), 0.1% of market cap
- EV/EBITDA multiple is 7.9x compared to historical level (75th percentile) of 8.6x
- EV/Sales multiple is 1.9x
At the opening of the session the share price went down -15.2% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #PAYC
@ saas
[Paycom Software](https://eninvs.com/all.php?name=PAYC) (Software provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190976)
(2025-08-06, After Market Close):
- Revenue +10.5% YoY (vs +6.2% in previous quarter and historical rate +17.9%)
- EBITDA +17.6% YoY (vs -29.2% in previous quarter and historical rate +26.7%)
- EBITDA margin 31.8% increased compared to 29.9% same period last year
- Net Debt decreased by $12 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.7% of market cap
- EV/EBITDA multiple is 17.6x compared to historical level (75th percentile) of 33.5x
- EV/Sales multiple is 6.4x
At the opening of the session the share price went up +7.0% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #Z
@ real-estate-tech
[Zillow](https://eninvs.com/all.php?name=Z) (Online real estate market) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190809)
(2025-08-06, After Market Close):
- Revenue +14.5% YoY (vs +13.0% in previous quarter and historical rate -16.7%)
- EBITDA +166.7% YoY (vs +409.1% in previous quarter and historical rate +57.6%)
- EBITDA margin 8.5% increased compared to 3.7% same period last year
- Net Debt increased by $80 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$0 bln (negative), 0.2% of market cap
- EV/EBITDA multiple is 151.9x compared to historical level (75th percentile) of 354.8x
- EV/Sales multiple is 7.8x
At the opening of the session the share price went down -2.9% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #TRMB
@ artificial-intelligence
[Trimble](https://eninvs.com/all.php?name=TRMB) (Software provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191038)
(2025-08-06, Before Market Open):
- Revenue +0.6% YoY (vs -11.8% in previous quarter and historical rate -1.4%)
- EBITDA +23.1% YoY (vs -43.0% in previous quarter and historical rate -7.1%)
- EBITDA margin 14.6% increased compared to 11.9% same period last year
- Net Debt increased by $146 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) -$0.1 bln (negative), 0.7% of market cap
- EV/EBITDA multiple is 40x compared to historical level (75th percentile) of 26.5x
- EV/Sales multiple is 6.2x
At the opening of the session the share price went up +4.2% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #TTD
@ adtech , @ artificial-intelligence
[Trade Desk](https://eninvs.com/all.php?name=TTD) (Marketing services provider ) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190741)
(2025-08-07, After Market Close):
- Revenue +18.6% YoY (vs +25.5% in previous quarter and historical rate +24.7%)
- EBITDA +23.3% YoY (vs +56.0% in previous quarter and historical rate +82.6%)
- EBITDA margin 20.6% increased compared to 19.8% same period last year
- Net Debt increased by $61 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$0.5 bln (positive), 2.0% of market cap
- EV/EBITDA multiple is 40.3x compared to historical level (75th percentile) of 179x
- EV/Sales multiple is 9.5x
At the opening of the session the share price went down -35.9% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #YUMC
@ china
[Yum China](https://eninvs.com/all.php?name=YUMC) (Restaurant chain owner) reported for 2025 q2
(2025-08-05, Before Market Open):
- Revenue +4% YoY (vs +0.8% in previous quarter and historical rate +6.2%)
- EBITDA +4.4% YoY (vs +3.5% in previous quarter and historical rate +14.3%)
- EBITDA margin 18.8% has not changed compared to 18.7% same period last year
- Net Debt decreased by $282 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) +$1.7 bln (positive), 10.4% of market cap
- EV/EBITDA multiple is 8.4x compared to historical level (75th percentile) of 11.2x
- EV/Sales multiple is 1.5x
At the opening of the session the share price went up +1.1% vs S&P500 +0.1%
------------------------------------------------
2025-08-09
#reports #STAA
[STAAR Surgical Co](https://eninvs.com/all.php?name=STAA) (Implantable contact lenses manufacturer ) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190695)
(2025-08-06, After Market Close):
- Revenue -55.6% YoY (vs -44.2% in previous quarter and historical rate -1.4%)
- EBITDA -315.4% YoY (vs -5600.0% in previous quarter)
- EBITDA margin -63.6% decreased compared to 13.1% same period last year
- Net Debt increased by $9 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) -$0 bln (negative), 1.5% of market cap
- EV/Sales multiple is 5.4x
------------------------------------------------
2025-08-09
#reports #SRI
[Stoneridge](https://eninvs.com/all.php?name=SRI) (Automotive electronic equipment manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190693)
(2025-08-06, After Market Close):
- Revenue -3.8% YoY (vs -8.8% in previous quarter and historical rate +19.8%)
- EBITDA -100% YoY (vs -200.0% in previous quarter and historical rate +0.1%)
- Net Debt decreased by $7 mln over the past reporting period (3.2% of market cap)
- FCF (LTM) +$0 bln (positive), 10.7% of market cap
- EV/EBITDA multiple is 21.2x compared to historical level (75th percentile) of 15.5x
- EV/Sales multiple is 0.3x
At the opening of the session the share price went down -3.8% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #SPR
[Spirit AeroSystems](https://eninvs.com/all.php?name=SPR) (Commercial aircraft structures manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190691)
(2025-08-04, After Market Close):
- Revenue +9.6% YoY (vs -10.6% in previous quarter and historical rate +12.9%)
- EBITDA margin -24.8% decreased compared to -17.2% same period last year
- Net Debt decreased by $272 mln over the past reporting period (6.1% of market cap)
- FCF (LTM) -$0.3 bln (negative), 7.8% of market cap
- EV/Sales multiple is 1.4x
At the opening of the session the share price went up +0.1% vs S&P500 +0.1%
------------------------------------------------
2025-08-09
#reports #SMSI
[Smith Micro Software](https://eninvs.com/all.php?name=SMSI) (Software — Application) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190687)
(2024-08-01, After Market Close):
- Revenue -20% YoY (vs -16.7% in previous quarter and historical rate -29.0%)
- EBITDA margin -350.0% decreased compared to -100.0% same period last year
- Net Debt increased by $1 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) -$0 bln (negative), 4.1% of market cap
- EV/Sales multiple is 2.6x
At the opening of the session the share price went down -18.5% vs S&P500 -1.3%
------------------------------------------------
2025-08-09
#reports #SMP
[Standard Motor Products](https://eninvs.com/all.php?name=SMP) (Auto parts manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190686)
(2025-08-04, Before Market Open):
- Revenue +26.7% YoY (vs +24.8% in previous quarter and historical rate +6.8%)
- EBITDA +68.8% YoY (vs +59.1% in previous quarter and historical rate +0.7%)
- EBITDA margin 10.9% increased compared to 8.2% same period last year
- Net Debt decreased by $23 mln over the past reporting period (2.7% of market cap)
- FCF (LTM) -$0.4 bln (negative), 44.9% of market cap
- EV/EBITDA multiple is 10.4x compared to historical level (75th percentile) of 9.7x
- EV/Sales multiple is 0.9x
At the opening of the session the share price went neutrally vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #SLNG
[Stabilis Solutions](https://eninvs.com/all.php?name=SLNG) (Oil and Gas Integrated) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190684)
(2025-08-06, After Market Close):
- Revenue -10.5% YoY (vs -15.0% in previous quarter and historical rate +0.6%)
- EBITDA -50% YoY (vs -100.0% in previous quarter and historical rate +13.9%)
- EBITDA margin 5.9% decreased compared to 10.5% same period last year
- Net Debt decreased by $4 mln over the past reporting period (4.8% of market cap)
- FCF (LTM) -$0 bln (negative), 3.6% of market cap
- EV/EBITDA multiple is 19.7x compared to historical level (75th percentile) of 16.8x
- EV/Sales multiple is 1.1x
At the opening of the session the share price went down -1.9% vs S&P500 +0.5%
------------------------------------------------
2025-08-09
#reports #SKIN
[The Beauty Health Company](https://eninvs.com/all.php?name=SKIN) (Special purpose acquisition company) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190683)
(2025-08-07, After Market Close):
- Revenue -14.3% YoY (vs -13.6% in previous quarter and historical rate +0.3%)
- EBITDA margin -146.2% has not changed compared to -146.2% same period last year
- Net Debt decreased by $30 mln over the past reporting period (12.7% of market cap)
- FCF (LTM) +$0 bln (positive), 10.2% of market cap
- EV/Sales multiple is 1.3x
At the opening of the session the share price went up +27.0% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #SHO
[Sunstone Hotel Investors](https://eninvs.com/all.php?name=SHO) (REIT — Hotel and Motel) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190681)
(2025-08-06, Before Market Open):
- Revenue +3.2% YoY (vs +7.8% in previous quarter and historical rate +9.0%)
- EBITDA -5.8% YoY (vs +6.5% in previous quarter and historical rate +16.7%)
- EBITDA margin 25.0% decreased compared to 27.4% same period last year
- Net Debt increased by $24 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) -$0.1 bln (negative), 3.3% of market cap
- EV/EBITDA multiple is 14x compared to historical level (75th percentile) of 13.2x
- EV/Sales multiple is 3x
At the opening of the session the share price went down -3.1% vs S&P500 +0.2%
------------------------------------------------
2025-08-09
#reports #SHLS
[Shoals Technologies Group, Inc.](https://eninvs.com/all.php?name=SHLS) (Solar) reported for 2025 q2
(2025-08-05, Before Market Open):
- Revenue +12.1% YoY (vs -11.0% in previous quarter and historical rate +23.4%)
- EBITDA -13.6% YoY (vs -46.7% in previous quarter and historical rate +49.1%)
- EBITDA margin 17.1% decreased compared to 22.2% same period last year
- Net Debt increased by $21 mln over the past reporting period (2.7% of market cap)
- FCF (LTM) +$0 bln (positive), 4.8% of market cap
- EV/EBITDA multiple is 16.6x compared to historical level (75th percentile) of 37.5x
- EV/Sales multiple is 2.3x
At the opening of the session the share price went up +7.8% vs S&P500 +0.1%
------------------------------------------------
2025-08-09
#reports #SGU
[Star Group](https://eninvs.com/all.php?name=SGU) (Oil and Gas Midstream) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190677)
(2025-07-30, After Market Close):
- Revenue -7.8% YoY (vs +11.6% in previous quarter and historical rate -1.7%)
- EBITDA margin -3.6% decreased compared to -1.8% same period last year
- Net Debt decreased by $27 mln over the past reporting period (6.7% of market cap)
- FCF (LTM) -$0.1 bln (negative), 24.5% of market cap
- EV/EBITDA multiple is 5.2x compared to historical level (75th percentile) of 12.6x
- EV/Sales multiple is 0.4x
